Chapter 1. Imaging in Clinical Trials Market- Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Imaging in Clinical Trials Market- Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
      2.3.1    Impact during 2023 – 2030
      2.3.2    Impact on Supply – Demand
Chapter 3. Imaging in Clinical Trials Market- Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Imaging in Clinical Trials Market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
      4.4.1     Bargaining Power of Suppliers
      4.4.2     Bargaining Powers of Customers
      4.4.3    Threat of New Entrants
      4.4.4     Rivalry among Existing Players
      4.4.5    Threat of Substitutes
Chapter 5. Imaging in Clinical Trials Market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Imaging in Clinical Trials Market- By Curative Area
6.1    Cardiovascular
6.2    Immunology
6.3     Hepatology
6.4    Arthritis
6.5     Osteoporosis
6.6    Orthopedics
6.7    Ophthalmology
6.8    Dermatology
6.9    Oncology
Chapter 7. Imaging in Clinical Trials Market- By Mode
7.1    X-Ray
7.2    Fluoroscopy
7.3    Ultrasound
7.4    MRI
7.5     CT (Computed Tomography)
7.6    PET
7.7     Prior-Clinical Imaging
7.8     Echocardiography
Chapter 8. Imaging in Clinical Trials Market- By End User
8.1    Medical gadget makers
8.2     Medicament companies
8.3    Government research bodies
8.4     Private research institutes
8.5     Bio-Tech companies
Chapter 9. Imaging in Clinical Trials Market– By Region
9.1    North America
9.2    Europe
9.3    Asia-Pacific
9.4    Latin America
9.5    The Middle East
9.6    Africa
Chapter 10. Imaging in Clinical Trials Market– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1    Company 1
10.2    Company 2
10.3    Company 3
10.4    Company 4
10.5    Company 5
10.6    Company 6
10.7    Company 7
10.8    Company 8
10.9    Company 9
10.10    Company 10